Baihakki, Ibno Salam L.
HRN: 25-25-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2024
CEFTAZIDIME 1GM (VIAL)
06/09/2024
06/16/2024
IV
2 Grams
Every 8 Hours
T/C CAP MR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes